Entering text into the input field will update the search result below

Aurinia nabs patent in U.S. for voclosporin dosing protocol for LN; shares up 3% premarket

  • The USPTO has issued a notice of allowance to Aurinia Pharmaceuticals (NASDAQ:AUPH) for patent application 15/835,219, entitled “PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS”.
  • The allowed claims cover a method of modifying the dose of voclosporin in patients with lupus nephritis (LN) based on patient specific pharmacodynamic parameters.
  • The U.S. patent is expected to be issued with a term extending to December 2037.
  • The Company has also filed for protection of this subject matter under the Patent Cooperation Treaty.
  • Shares are up 3% premarket.

Recommended For You

About AUPH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AUPH--
Aurinia Pharmaceuticals Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.